Geftin 250mg Tablet is a targeted therapy medication used in the treatment of certain types of cancer. Its active ingredient is Gefitinib, a tyrosine kinase inhibitor (TKI). Gefitinib works by blocking the activity of a specific protein called the epidermal growth factor receptor (EGFR) tyrosine kinase. In some cancer cells, EGFR is overactive, promoting cell growth and division. By inhibiting this pathway, Gefitinib helps to slow down or stop the growth of these cancer cells.
Geftin 250mg Tablet is primarily indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have specific EGFR mutations. It is typically used as a first-line treatment for these patients.
The usual dosage is one 250mg tablet taken orally once a day. It can be taken with or without food. The duration of treatment depends on the patient’s response and tolerance. Common side effects may include diarrhea, rash, acneiform dermatitis, dry skin, nausea, vomiting, and stomatitis. Less common but serious side effects can occur, so it is crucial to discuss any concerns with a healthcare professional.
Geftin 250mg Tablets should be stored at room temperature, away from moisture and heat. Keep out of reach of children.
